Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal [1]

Movement Disorders

Volumn 20, Issue 12, 2005, Pages 1671-

  Thomas, Astrid ^a   Onofrj, Marco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CREATINE KINASE; LEVODOPA; MYOGLOBIN; ANTIPARKINSON AGENT; NEUROLEPTIC AGENT;

AKINESIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; HUMAN; HYPERPYREXIA; LETTER; NEUROLEPTIC MALIGNANT SYNDROME; NOMENCLATURE; NOSE FEEDING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; RIGIDITY; CLASSIFICATION; MALIGNANT HYPERTHERMIA; MOTOR DYSFUNCTION; NOTE; PATHOPHYSIOLOGY; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; HUMANS; MALIGNANT HYPERTHERMIA; MOVEMENT DISORDERS; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSONIAN DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33644944523     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20689     Document Type: Letter

References (5)

1. Kipps CM, Fung VSC, Grattan-Smith P, de Moore GM, Morris JGL. Movement disorder emergencies. Mov Disord 2005;20:322-334.
2. Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64:1162-1169.
3. Friedman JH, Feinberg SS, Feldman RC. Neuroleptic malignantlike syndrome due to L-dopa withdrawal. Ann Neurol 1984;16:126.
4. Danielczyk W. Die Behandlung von akinetischen Krisen. Med Welt 1973;24:1278-1282.
5. Takubo H, Harada T, Hashimoto T, et al. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003;9:S31-S41.